1. Home
  2. RCUS vs SBH Comparison

RCUS vs SBH Comparison

Compare RCUS & SBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • SBH
  • Stock Information
  • Founded
  • RCUS 2015
  • SBH 1964
  • Country
  • RCUS United States
  • SBH United States
  • Employees
  • RCUS N/A
  • SBH N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • SBH Other Specialty Stores
  • Sector
  • RCUS Health Care
  • SBH Consumer Discretionary
  • Exchange
  • RCUS Nasdaq
  • SBH Nasdaq
  • Market Cap
  • RCUS 906.4M
  • SBH 937.3M
  • IPO Year
  • RCUS 2018
  • SBH 2006
  • Fundamental
  • Price
  • RCUS $8.54
  • SBH $9.81
  • Analyst Decision
  • RCUS Buy
  • SBH Buy
  • Analyst Count
  • RCUS 10
  • SBH 6
  • Target Price
  • RCUS $23.75
  • SBH $12.70
  • AVG Volume (30 Days)
  • RCUS 1.2M
  • SBH 1.7M
  • Earning Date
  • RCUS 08-07-2025
  • SBH 08-07-2025
  • Dividend Yield
  • RCUS N/A
  • SBH N/A
  • EPS Growth
  • RCUS N/A
  • SBH 18.05
  • EPS
  • RCUS N/A
  • SBH 1.76
  • Revenue
  • RCUS $141,000,000.00
  • SBH $3,698,409,000.00
  • Revenue This Year
  • RCUS N/A
  • SBH N/A
  • Revenue Next Year
  • RCUS $28.73
  • SBH $1.40
  • P/E Ratio
  • RCUS N/A
  • SBH $5.61
  • Revenue Growth
  • RCUS N/A
  • SBH 0.17
  • 52 Week Low
  • RCUS $6.50
  • SBH $7.54
  • 52 Week High
  • RCUS $18.98
  • SBH $14.79
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 46.40
  • SBH 65.78
  • Support Level
  • RCUS $7.92
  • SBH $8.66
  • Resistance Level
  • RCUS $8.61
  • SBH $10.15
  • Average True Range (ATR)
  • RCUS 0.45
  • SBH 0.31
  • MACD
  • RCUS -0.09
  • SBH 0.11
  • Stochastic Oscillator
  • RCUS 40.00
  • SBH 80.00

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)

Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.

Share on Social Networks: